| Autor: |
Walz JC; Bipolar Disorders Program, Centro de Pesquisas, Hospital de Clínicas de Porto Alegre, and Department of Biochyemistry, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil., Andreazza AC, Frey BN, Cacilhas AA, Ceresér KM, Cunha AB, Weyne F, Stertz L, Santin A, Gonçalves CA, Kapczinski F |
| Jazyk: |
angličtina |
| Zdroj: |
Neuroscience letters [Neurosci Lett] 2007 Mar 19; Vol. 415 (1), pp. 87-9. Date of Electronic Publication: 2007 Jan 17. |
| DOI: |
10.1016/j.neulet.2007.01.002 |
| Abstrakt: |
Accumulating evidence suggest that neural changes and cognitive impairment may accompany the course of bipolar disorder. Such detrimental effects of cumulative mood episodes may be related to changes in neurotrophins that take place during mood episodes but not during euthymic phases. The present study investigated serum neurotrophin-3 (NT-3) levels in patients with bipolar disorder during manic, depressed, and euthymic states, using an enzyme-linked immunosorbent assay (sandwich-ELISA). Serum NT-3 levels were increased in manic (p<0.001) and depressed (p<0.001) BD patients, as compared with euthymic patients and normal controls. These findings suggest that the NT-3 signaling system may play a role in the pathophysiology of BD. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect